thomsonreuters.com
Thomson Reuters

Solutions for:
Solutions at a glance


Look through a clinician's eyes

Example Screen

View a screenshot

Click on the thumbnail to view a full-size example screen.

Measure and compare the potential impact of published scientific information

Clinicians typically have approximately three to four hours per week to digest key information. So it’s essential to ensure they are receiving balanced information about your products.

The Thomson Message Mapping SystemSM measures the potential impact of published scientific information on the clinical practices of healthcare professionals by ranking it in a way that reflects their selection and reading processes.

You can critically evaluate how the information published about your products, in scientific literature or at major medical meetings, supports or detracts from the key clinical concepts and messages associated with those products.

You can understand the role and impact of key scientific publications on clinical practices and ascertain how messages about your product are being perceived from the point of view of the prescribing clinician.

Providing a clinical perspective

The Thomson Message Mapping System utilizes a patented process by which the key ideas and messages published about a product in journal articles, abstracts, monographs, posters, and more, are identified, categorized, and quantitatively scored. The results can then be used to assess the impact these messages will have.  

Receive a quotation or product demonstration

Contact us today for more information click here.


Further information

Click here to download the Thomson Message Mapping System fact sheet

 

Can help you to
  • Plan your research and publication strategies
  • Differentiate your products in the market
  • Determine which messages are reaching your key target audience
  • Monitor your communications programs
  • Benchmark your product’s messages against market leaders
  • Focus on literature that has a critical impact
  • Respond swiftly to competitive threats

Who can benefit
  • Professionals at all stages of drug development
  • Pharmaceutical companies with existing products in the market
  • Innovators making the transition from Phase II to Phase III
  • Pharmaceutical companies preparing to launch

Related solutions

Scientific Home   |   About Scientific   |   Site Search   |   Site Map
Copyright Notices   |   Terms of Use   |   Privacy Statement